Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 13.81T | 13.02T | 11.54T | 9.92T | 9.00T | 8.26T |
Gross Profit | 3.67T | 3.33T | 3.14T | 2.70T | 2.44T | 2.33T |
EBITDA | 2.68T | 2.45T | 2.31T | 2.06T | 1.64T | 1.56T |
Net Income | 1.13T | 970.57B | 1.01T | 882.18B | 1.03T | 582.19B |
Balance Sheet | ||||||
Total Assets | 35.99T | 34.11T | 31.15T | 29.65T | 27.51T | 24.97T |
Cash, Cash Equivalents and Short-Term Investments | 3.08T | 2.33T | 1.83T | 2.47T | 2.22T | 1.92T |
Total Debt | 4.38T | 4.09T | 4.06T | 3.57T | 2.65T | 2.05T |
Total Liabilities | 27.47T | 26.35T | 24.50T | 23.95T | 20.78T | 18.97T |
Stockholders Equity | 8.19T | 7.59T | 6.60T | 5.65T | 6.68T | 4.87T |
Cash Flow | ||||||
Free Cash Flow | 3.18T | 749.27B | -298.94B | 792.55B | 837.91B | 909.98B |
Operating Cash Flow | 3.89T | 1.37T | 314.69B | 1.23T | 1.35T | 1.35T |
Investing Cash Flow | -977.10B | -818.89B | -1.05T | -728.78B | -1.78T | -1.35T |
Financing Cash Flow | -722.49B | -210.71B | 84.30B | -336.58B | 666.97B | 65.66B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | $3.15T | 32.95 | 138.02% | 0.49% | 4.91% | -0.36% | |
74 Outperform | $149.53B | 19.74 | 14.32% | 0.52% | -5.46% | 14.01% | |
68 Neutral | $278.42M | 19.06 | 12.49% | ― | 44.41% | ― | |
63 Neutral | $33.91B | 5.95 | -11.88% | 1.83% | 5.33% | -18.39% | |
63 Neutral | $1.26B | ― | -15.80% | ― | -5.24% | -67.92% | |
55 Neutral | $3.35B | ― | -28.93% | ― | 17.34% | 34.72% | |
52 Neutral | $126.55M | ― | -83.57% | ― | -20.88% | 62.21% |